Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, ...

Prenatal screening empowers expectant parents with vital knowledge that helps them make informed decisions during a delicate phase of life. Not just intellectual disabilities Down Syndrome can also le ...

While fertility does decline with age, many women have successfully delivered babies after the age of 40, notes Dr Rohan ...

Strong 2025 financials and raised outlook: BillionToOne reported 100% year‑over‑year revenue growth for 2025 with positive GAAP operating income, $38.8M adjusted EBITDA (13% margin) and Q4 revenue of ...

Q4 2025 Earnings Call March 4, 2026 4:30 PM ESTCompany ParticipantsDavid Deuchler - Managing DirectorOguzhan Atay - ...

Testing Market size is USD 2.24 Billion in 2025 and is expected to reach USD 6.66 Billion by 2035 due to the increasing adoption of NIPTAustin, March 10, 2026 (GLOBE NEWSWIRE) -- According to SNS ...

Medical experts are urging parents, particularly women over 35 or those with a family history of genetic disorders, to seek medical advice during pregnancy. They warn that early detection of ...

Detailed price information for Billiontoone Inc Cl A (BLLN-Q) from The Globe and Mail including charting and trades.

Get Pregnancy tests latest news, Article video and Photos on Pregnancy tests Explore latest health updates, news, information from TheHealthSite.com ...

Fulgent Genetics Inc (FLGT) reports a 14% annual revenue increase, strategic acquisitions, and new market opportunities despite facing significant customer revenue loss.

BillionToOne Inc (BLLN) reports a remarkable 113% revenue increase and outlines ambitious growth plans for 2026 amidst competitive challenges.